Jutta Deckert

Contact Jutta

Jutta Deckert

Executive Director, Translational R&D

Iksuda Therapeutics

R&D Director with 18 years of industry experience in oncology and immuno-oncology drug research and development. Experienced with cross-functional program team leadership and management of R&D groups for internal programs and external collaborations. Broad knowledge of cell biology, pharmacology, translational medicine and clinical biomarker development to advance programs from target validation to clinical POC. Comprehensive expertise in discovery and clinical development of antibodies, ADCs and cell-based therapies for solid tumors and hematologic malignancies. Demonstrated leadership skills at the team, program and portfolio strategy level.

Talks About
#translationalresearch #oncology

Preferred Locations
#NorthAmerica

Speaking Engagements

ADC Toxicity Summit

Paid

Toxicity remains the single biggest hurdle in getting ADCs to market, and drug developers are striving to develop safer antibody drug conjugates while keeping efficacy high. Although ADCs have come far, there are still more advancements to be made, highlighted by the blockbuster Enhertu and the recently approved Elahere, both containing Black Box W

25-27 July 2023

Healthcare

Festival of Biologics USA 2024

Paid

Join us at the Festival of Biologics USA 2024, the most exciting biologics event in America! Taking place from April 15 to 17, 2024, at the renowned San Diego Convention Center, this three-day event will cover the entire journey of biologic drug development, from discovery to market access.

With nine comprehensive tracks covering discovery,

15-17 April 2024

Healthcare

Claim Your Profile Request

Speaker Contact Request

SPEAKER

Jutta Deckert

Executive Director, Translational R&D

Speaking Engagements

ADC Toxicity Summit

Festival of Biologics USA 2024